Inventor
Heiko Schuster
Inventor
Tuebingen, DE
Overview
Patents· 87 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07KPeptides19%
C12NMicroorganisms or enzymes18%
C07DHeterocyclic compounds12%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology2%
C12YEnzymes0%
PatentTitleYear
11,117,941B*44 restricted peptides for use in immunotherapy against cancers and related methods202111,111,281B*44 restricted peptides for use in immunotherapy against cancers and related methods202111,103,535Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,077,142Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,078,253Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers202111,071,756Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers202111,065,279Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,058,727Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,058,755A*03 restricted peptides for use in immunotherapy against cancers and related methods202111,052,113Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,053,296Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers202111,052,114Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,040,069Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,033,583Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,033,585Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,026,977Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,020,434Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,020,433Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,013,766Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,013,769Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,013,768Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202111,014,972B*44 restricted peptides for use in immunotherapy against cancers and related methods202111,001,617Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods202110,993,964Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,993,962Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,954,281Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods202110,946,081*03 restricted peptides for use in immunotherapy against cancers and related methods202110,925,947A*03 restricted peptides for use in immunotherapy against cancers and related methods202110,905,719Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,905,720Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,899,813Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods202110,899,820Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers202110,899,810B*44 restricted peptides for use in immunotherapy against cancers and related methods202110,898,518Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,898,519Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,899,814Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods202110,899,812Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods202110,899,811B*44 restricted peptides for use in immunotherapy against cancers and related methods202110,894,064Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,888,582Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,888,583Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,888,585Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,888,587Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers202110,888,584Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,888,586Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202110,881,690Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers202110,874,696Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,874,695Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,869,892Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,869,896Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,869,893Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,869,897Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers202010,869,895Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,869,891Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,869,890Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,869,894Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,869,917A*03 restricted peptides for use in immunotherapy against cancers and related methods202010,870,685Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods202010,828,357A*03 restricted peptides for use in immunotherapy against cancers and related methods202010,822,627Mutants of hydantoinase202010,813,953Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,799,537Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,792,307Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,792,308Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,780,124Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,781,244Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers202010,780,122Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,780,123Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,772,915Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,751,369Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,738,100Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers202010,722,538Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers202010,709,736Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,709,738Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,709,737Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,702,553Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,695,376Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,695,374Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,695,377Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,695,375Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,695,373Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers202010,639,331Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers202010,639,332Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers202010,568,909Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers202010,463,696Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers20199,957,536Mutants of hydantoinase20189,889,159'Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers'2018Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2018–2021Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (85)· patent assignee history
2018–2020Patents assigned to EVONIK TECHNOCHEMIE GMBH (2)· patent assignee history
2018Patents assigned to EVONIK INDUSTRIES AG (1)· patent assignee history
2018–2021Based in Tuebingen, DE· patent location history
2018–2020Based in Hanau, DE· patent location history
2020Patents assigned to EVONIK OPERATIONS GMBH (1)· patent assignee history
2021Based in Tubingen, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMATICS BIOTECHNOLOGIES GMBH | 85 | 2018–2021 |
| EVONIK TECHNOCHEMIE GMBH | 2 | 2018–2020 |
| EVONIK INDUSTRIES AG | 1 | 2018 |
| EVONIK OPERATIONS GMBH | 1 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Tuebingen, DE | 84 | 2018–2021 |
| Hanau, DE | 2 | 2018–2020 |
| Tubingen, DE | 1 | 2021 |